Jordan J, Tank J, Reuter H. Carotid Baroreceptor Stimulation. In: Hypertension and Heart Failure: Epidemiology, Mechanisms and Treatment, 2019: Seiten 363 – 375. Dorobantu M, Mancia G, Grassi G, Voicu V (Hrsg.). ISBN 978-3-319-93320-7.
Reuter H, Beige J, Halbach M, Wallbach M, Mader N, Zenker D, Hennig G, Mahfoud F, Schlieper G, Schwenger V, Hausberg M, Börgel J, Lodde M, van der Giet M, Müller-Ehmsen J, Passauer J, Parmentier S, Lüders S, Krämer BK, Büttner S, Limbourg F, Jordan J, Vonend O, Predel HG, Koziolek M.
Baroreflex activation therapy in treatment-resistant hypertension. Recommendations of the BAT consensus group on implantation and aftercare.
Nephrologe 2019, 14:124–133
Jordan J, Tank J, Reuter H. Risk-Benefit Assessment of Intense Blood Pressure Lowering. Hypertension 2019; 74:1302-1304
https://cutt.ly/1yny5Wm
Jordan J, Fanciulli A, Tank J, Calandra-Buonaura G, Cheshire WP, Cortelli P, Eschlboeck S, Grassi G, Hilz MJ, Kaufmann H, Lahrmann H, Mancia G, Mayer G, Norcliffe-Kaufmann L, Pavy-Le Traon A, Raj SR, Robertson D, Rocha I, Reuter H, Struhal W, Thijs RD, Tsioufis KP, Gert van Dijk J, Wenning GK, Biaggioni I.
Management of supine hypertension in patients with neurogenic orthostatic hypotension: scientific statement of the American Autonomic Society, European Federation of Autonomic Societies, and the European Society of Hypertension.
Journal of Hypertension 2019, 37:1541–1546.
https://cutt.ly/KyntsOu
Jordan J, Tank J, Heusser K, Reuter H, Biaggioni I.
What do we really know about supine hypertension in patients with orthostatic hypotension.
Curr Opin Cardiol 2019, 34:384–389.
https://cutt.ly/yyntxQD
Reuter H und Jordan J.
Status of hypertension in Europe.
Curr Opin Cardiol 2019, 34:342–349.
https://cutt.ly/ryntbGI
Johannsen JO, Reuter H, Hoffmann F, Blaich C, Wiesen MHJ, Streichert T, Müller C.
Reliable and easy-to-use LC-MS/MS-method for simultaneous determination of the antihypertensives metoprolol, amlodipine, canrenone and hydrochlorothiazide in patients with therapy-refractory arterial hypertension.
J Pharm Biomed Anal. 2019; 164:373-381.
https://cutt.ly/byntQ7S
Halbach M, Grothaus D, Hoffmann F, Madershahian N, Kuhr K, Reuter H.
Baroreflex activation therapy reduces frequency and duration of hypertension-related hospitalizations in patients with resistant hypertension.
Clin Auton Res 2019; im Druck.
https://cutt.ly/EyntGw5
Adler C, Schregel F, Heller T, Hellmich M, Adler J, Reuter H.
Malignant Arrhythmias During Induction of Target Temperature Management After Cardiac Arrest.
Ther Hypothermia Temp Manag 2019; im Druck.
https://cutt.ly/RyntYJp